Boeing (BA) price target was boosted at Drexel Hamilton. Shares now seen reaching $110. Company is running a record backlog and can expand margins, Drexel Hamilton said. Buy rating.
Bristol-Myers (BMY) estimates were reduced at Leerink Swann through 2014. Company is seeing lower Eliquis sales, Leerink Swann said. Market Perform rating.
Brocade (BRCD) estimates, price target were reduced at Craig-Hallum. Shares are now seen reaching $5.50. Estimates were also cut, given lackluster storage results, Craig-Hallum said. Hold rating.
Cognizant (CTSH) price target and estimates were reduced at UBS. Estimates were cut to reflect the uncertainty surrounding the visa debate, said UBS. Price target goes to $68.DR Horton (DHI) numbers were increased at Credit Suisse through 2014. Higher sales should drive margin expansion, Credit Suisse said. Outperform rating and new $28 price target. DTE Energy (DTE) estimates were increased at UBS ahead of the company's analyst day. Cost savings continue, and an update on the multiyear road map is expected to be announced, UBS said. GNC (GNC) estimates, price target were boosted at BMO Capital. Shares are now seen reaching $50. Estimates were also increased, given better pricing. Outperform rating. Lifepoint estimates, price target were raised at Credit Suisse. Shares are now seen reaching $48. Estimates were also increased, as acqusitions are adding to earnings and the company is keeping a tight lid on costs, Credit Suisse said. Neutral rating. 3M (MMM) estimates were reduced at UBS. Estimates were reduced given tough macro conditions in the first quarter, said UBS. FX will also be more of a headwind for the company than originally expected, UBS also said. Molina estimates, price target were raised at Cantor Fitzgerald. Shares are now seen reaching $35. Estimates were also increased, given the company's new guidance, Cantor said. Hold rating. Oil States (OIS) numbers were cut at Credit Suisse through 2014. Company lowered its guidance, Credit Suisse said. Neutral rating and new $78 price target. PVH (PVH) was added to the Focus List at Credit Suisse. $139 price target. Accelerated revenue growth should boost margins, Credit Suisse said. Regeneron (REGN) estimates, price target were increased at Bank of America/Merrill Lynch. Estimates were increased through 2015. Company can continue to deliver robust growth, BofA/Merrill said. Buy rating and new $240 price target. Boston Beer (SAM) price target and estimates were increased at UBS. Estimates were raised to reflect the success of Angry Orchard, said UBS. Price target goes to $143. VF Corp. (VFC) numbers were boosted at Credit Suisse. Shares are now seen reaching $188. Estimates were also increased, as the company is expanding margins, Credit Suisse said. Outperform rating. VF Corp. price target and estimates were increased at UBS. Estimates were raised given solid margins and an encouraging outlook for innovative platforms, said UBS. Price target goes to $191. WisdomTree Investments estimates were reduced at Citigroup. Earnings estimates were reduced given disappointing cost guidance, said Citigroup. Wynn (WYNN) estimates, price target were increased at Morgan Stanley. Estimates were raised through 2014. Macau should drive growth, and the company is cutting costs in Las Vegas, Morgan Stanley said. Equal-weight rating and new $140 price target. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts